ASHLAND, OR / ACCESS Newswire / July 15, 2025 / Satya Therapeutics, a leading psilocybin service center and manufacturer in Oregon, has announced a series of significant achievements that reinforce its leadership in the state's rapidly expanding psychedelic wellness industry.

Manufacturing License Renewal

• Renewed License: Satya Therapeutics successfully renewed its Oregon Psilocybin Manufacturing License on June 30 with the Oregon Health Authority (OHA).

• Continued Innovation: The renewal allows Satya to continue producing its proprietary psilocybin mushroom blends, with specific formulas designed for clients on SSRIs and antipsychotics.

• Affordable Access: Commitment to affordable psilocybin products is highlighted by a current average price of $1.00 per milligram for service center partners. Plans for a forthcoming psilocybin cooperative aim to lower prices to $0.75 per mg or less, broadening access across the state.

Client Growth and Service Accessibility

• Client Milestones: Since its opening in July 2023, Satya expects to serve its 1,100th client this July.

• 2025 Growth: The first half of 2025 saw 286 clients, signaling robust, ongoing demand.

• Affordable Journeys: Individual, all-inclusive psilocybin sessions are available for $1,000-$1,250, supporting a diverse clientele seeking transformative care.

• Quality and Value: While not the lowest-priced option in Oregon, Satya emphasizes value through professional facilitation, premium mushrooms, a safe environment, and unlimited preparation and integration sessions at no extra cost.

• Client Feedback: The center boasts 111 five-star Google reviews, reflecting positive and safe client experiences.

Facilitator Expertise

• Industry-Leading Experience: Satya's facilitators are among the most experienced in Oregon, with four team members having guided over 100 clients each.

• Notable Facilitators:

  	Name	Clients Guided
  	Dr. Bonny Koeber	179
  	Dabney Finney	170
  	Andreas Met	161
  	Bern Haggard	117

• Sector Benchmark: In Oregon's nascent industry, more than 50 client sessions is recognized as highly significant-Satya's facilitators far surpass this, ensuring depth of expertise and trauma-informed support.

Industry Collaboration and Advocacy

• Psilocybin Alliance: Satya is a member of the newly established Psilocybin Alliance, a coalition advocating for inclusive, sustainable growth and best practices in the sector.

• Policy Engagement: Andreas Met, Satya's COO, recently participated in a key Alliance meeting with Oregon Psilocybin Services leadership, emphasizing Satya's role in shaping effective, pro-operator regulatory frameworks.

Commitment to Access, Quality, and Innovation

Satya Therapeutics remains dedicated to:

• Enhancing availability of safe, effective psilocybin services.

• Maintaining industry-leading standards through expert facilitation.

• Promoting affordability and inclusivity for all Oregonians interested in transformative psychedelic wellness.

For more information:

• Visit: satyatherapeutics.com

• Contact: andreas@satyatherapeutics.com

Satya Therapeutics - Dedicated to safe, affordable, and transformative psilocybin experiences guided by Oregon's most experienced facilitators.

SOURCE: SATYA INC.